Skip to content
OpenCapital
Get started

Gain Therapeutics GANX Q4 2024 Annual earnings

Reported March 27, 2025 · Before market open

EPS-$0.11Beat by $0.07
EPS estimate-$0.18

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$33.3K
EPS estimate-$0.14

Versus estimates

Diluted EPS

Q1 2026-$0.13In lineQ4 2025-$0.11Beat by $0.03Q3 2025-$0.15In lineQ2 2025-$0.19Miss by $0.02Q1 2025-$0.16In line
Q4 2024-$0.11Beat by $0.07

Ask the moment Gain Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Gain Therapeutics report Q4 2024 earnings?
Gain Therapeutics (GANX) reported Q4 2024 earnings on March 27, 2025 before market open.
What were Gain Therapeutics's Q4 2024 revenue and EPS?
Gain Therapeutics reported eps of $-0.11 for Q4 2024.
Did Gain Therapeutics beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.18 by $0.07.
Where can I find Gain Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-003823) directly on SEC EDGAR. The filing index links above go to sec.gov.